{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:23:45Z","timestamp":1794738225851,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The left ventricular assist devices (LVADs) are increasingly used for advanced heart failure as a bridge to heart transplantation or as a destination therapy. The aim of this study was to investigate the changes of diastolic pulmonary gradient (DPG), pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) after LVAD implantation and their impact on survival after LVAD and heart transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 73 patients who underwent LVAD (HeartMate III) implantation between 2016 and 2022 were retrospectively studied. According to pre-LVAD catheterization, 49 (67.1%) patients had DPG\u2009&lt;\u20097\u00a0mmHg and 24 (32.9%) patients had DPG\u2009\u2265\u20097\u00a0mmHg. The patients with a pre-VAD DPG\u2009\u2265\u20097\u00a0mmHg had higher frequencies of right ventricular (RV) failure (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), RVAD insertion (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), need for renal replacement therapy (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), total mortality (<jats:italic>p<\/jats:italic>\u2009=\u20090.036) and on-VAD mortality (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) with a longer ICU stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) compared to the patients with DPG\u2009&lt;\u20097\u00a0mmHg. During the follow-up period of 38 (12\u201360) months, 24 (32.9%) patients died. Pre-LVAD DPG\u2009\u2265\u20097\u00a0mmHg (adjusted HR 1.83, 95% CI 1.21\u20136.341, <jats:italic>p<\/jats:italic>\u2009=\u20090.039) and post-LVAD DPG\u2009\u2265\u20097\u00a0mmHg (adjusted HR 3.824, 95% CI 1.482\u201314.648, <jats:italic>p<\/jats:italic>\u2009=\u20090.002) were associated with increased risks of mortality. Neither pre-LVAD TPG\u2009\u2265\u200912 (<jats:italic>p<\/jats:italic>\u2009=\u20090.505) nor post-LVAD TPG\u2009\u2265\u200912\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009=\u20090.122) was associated with an increased risk of death. Pre-LVAD PVR\u2009\u2265\u20093 WU had a statistically insignificant risk of mortality (HR 2.35, 95% CI 0.803\u20136.848, <jats:italic>p<\/jats:italic>\u2009=\u20090.119) while post-LVAD PVR\u2009\u2265\u20093 WU had an increased risk of death (adjusted HR 2.37, 95% CI 1.241\u20137.254, <jats:italic>p<\/jats:italic>\u2009=\u20090.038). For post-transplantation mortality, post-LVAD DPG\u2009\u2265\u20097\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009=\u20090.55), post-LVAD TPG\u2009\u2265\u200912\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009=\u20090.85) and PVR\u2009\u2265\u20093 WU (<jats:italic>p<\/jats:italic>\u2009=\u20090.54) did not have statistically increased risks. The logistic multivariable regression showed that post-LVAD PVR\u2009\u2265\u20093 WU (<jats:italic>p<\/jats:italic>\u2009=\u20090.013), post-LVAD DPG\u2009\u2265\u20097\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009=\u20090.026) and RVF (<jats:italic>p<\/jats:italic>\u2009=\u20090.018) were the predictors of mortality after LVAD implantation. Pre-LVAD DPG\u2009\u2265\u20097\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and pre-LVAD PVR\u2009\u2265\u20093 WU (<jats:italic>p<\/jats:italic>\u2009=\u20090.036) were the predictors of RVF after LVAD implantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Persistently high DPG was associated with right ventricular failure and mortality after LVAD implantation rather than after heart transplantation. DPG is a better predictor of pulmonary vascular remodeling compared to TPG and PVR. Further larger prospective studies are required in this field due to the growing numbers of patients with advanced heart failure, as possible candidates for LVAD implantation, and limitations of heart transplantation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-023-00428-4","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:02:47Z","timestamp":1703080967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation"],"prefix":"10.1186","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-2813","authenticated-orcid":false,"given":"Mohamed","family":"Laimoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-5901","authenticated-orcid":false,"given":"Emad","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-4934","authenticated-orcid":false,"given":"Mary Jane","family":"Maghirang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-6546","authenticated-orcid":false,"given":"Tahir","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"428_CR1","doi-asserted-by":"crossref","unstructured":"Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T, ESCAPE Investigators (2009) Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J 157:1026\u20131034","DOI":"10.1016\/j.ahj.2009.02.022"},{"key":"428_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942\u2013954. https:\/\/doi.org\/10.1093\/eurheartj\/ehv512","journal-title":"Eur Heart J"},{"key":"428_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.amjcard.2006.11.052","volume":"99","author":"J Kjaergaard","year":"2007","unstructured":"Kjaergaard J, Akkan D, Iversen KK, Kjoller E, Kober L, Torp-Pedersen C, Hassager C (2007) Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 99:1146\u20131150","journal-title":"Am J Cardiol"},{"issue":"4","key":"428_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cjca.2020.11.003","volume":"37","author":"F Lee","year":"2021","unstructured":"Lee F, Mielniczuk LM (2021) Pulmonary hypertension due to left heart disease\u2014a practical approach to diagnosis and management. Can J Cardiol 37(4):572\u2013584. https:\/\/doi.org\/10.1016\/j.cjca.2020.11.003","journal-title":"Can J Cardiol"},{"key":"428_CR5","doi-asserted-by":"crossref","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67\u2013119","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"428_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1183\/09031936.00074312","volume":"41","author":"R Naeije","year":"2013","unstructured":"Naeije R, Vachiery JL, Yerly P, Vanderpool R (2013) The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 41:217\u2013223","journal-title":"Eur Respir J"},{"key":"428_CR7","doi-asserted-by":"publisher","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","volume":"62","author":"JL Vachiery","year":"2013","unstructured":"Vachiery JL, Adir Y, Barbera JA, Champion HC, Coghlan JG, Cottin V, De Marco T, Galie N, Ghio S, Gibbs JS, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Seeger W (2013) Pulmonary hypertension due to left heart disease. J Am Coll Cardiol 62:D100\u2013D108","journal-title":"J Am Coll Cardiol"},{"key":"428_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1378\/chest.12-1653","volume":"143","author":"C Gerges","year":"2013","unstructured":"Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM (2013) Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \u201cout-of-proportion\u201d pulmonary hypertension. Chest 143:758\u2013766","journal-title":"Chest"},{"key":"428_CR9","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, R\u00e5degran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, ESC\/ERS Scientific Document Group (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237. Erratum in: Eur Heart J. 2023;44(15):1312.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"428_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jtcvs.2010.05.042","volume":"140","author":"F Beyersdorf","year":"2010","unstructured":"Beyersdorf F, Schlensak C, Berchtold-Herz M, Trummer G (2010) Regression of \u201cfixed\u201d pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices. J Thorac Cardiovasc Surg 140:747\u2013749. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.05.042","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"428_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ejcts.2011.01.019","volume":"40","author":"E Mikus","year":"2011","unstructured":"Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, Lehmkuhl HB, Hetzer R, Potapov EV (2011) Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg 40(4):971\u2013977. https:\/\/doi.org\/10.1016\/j.ejcts.2011.01.019","journal-title":"Eur J Cardiothorac Surg"},{"key":"428_CR12","doi-asserted-by":"publisher","unstructured":"Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L (2009) Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg 35(6):1029\u20131034; discussion 1034\u20135. https:\/\/doi.org\/10.1016\/j.ejcts.2008.12.024.","DOI":"10.1016\/j.ejcts.2008.12.024"},{"issue":"2","key":"428_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.11.023","volume":"115","author":"M Yuzefpolskaya","year":"2023","unstructured":"Yuzefpolskaya M, Schroeder SE, Houston BA, Robinson MR, Gosev I, Reyentovich A, Koehl D, Cantor R, Jorde UP, Kirklin JK, Pagani FD, D\u2019Alessandro DA (2023) The Society of Thoracic Surgeons Intermacs 2022 annual report: focus on the 2018 Heart Transplant Allocation System. Ann Thorac Surg 115(2):311\u2013327. https:\/\/doi.org\/10.1016\/j.athoracsur.2022.11.023","journal-title":"Ann Thorac Surg"},{"key":"428_CR14","doi-asserted-by":"publisher","unstructured":"Al Habeeb W, Tash A, Elasfar A, Almasood A, Bakhsh A, Elshaer F, Al Ayoubi F, AIghalayini KW, AlQaseer MM, Alhussein M, Almogbel O, AlSaif SM, AlHebeshi Y (2023) 2023 National Heart Center\/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure. J Saudi Heart Assoc 35(1):71\u2013134. https:\/\/doi.org\/10.37616\/2212-5043.1334","DOI":"10.37616\/2212-5043.1334"},{"issue":"9","key":"428_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","volume":"25","author":"MR Mehra","year":"2006","unstructured":"Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20132006. J Heart Lung Transplant 25(9):1024\u20131042. https:\/\/doi.org\/10.1016\/j.healun.2006.06.008","journal-title":"J Heart Lung Transplant"},{"key":"428_CR16","doi-asserted-by":"publisher","unstructured":"Cowger JA, Naka Y, Aaronson KD, Horstmanshof D, Gulati S, Rinde-Hoffman D, Pinney S, Adatya S, Farrar DJ, Jorde UP, MOMENTUM 3 Investigators (2018) Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: a call for new metrics for left ventricular assist device patients. J Heart Lung Transplant 37(1):15\u201324. https:\/\/doi.org\/10.1016\/j.healun.2017.10.019","DOI":"10.1016\/j.healun.2017.10.019"},{"key":"428_CR17","doi-asserted-by":"publisher","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435\u20131443. https:\/\/doi.org\/10.1056\/NEJMoa012175","DOI":"10.1056\/NEJMoa012175"},{"key":"428_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.875204","volume":"9","author":"A Grupper","year":"2022","unstructured":"Grupper A, Mazin I, Faierstein K, Kurnick A, Maor E, Elian D, Barbash IM, Guetta V, Regev E, Morgan A, Segev A, Lavee J, Fefer P (2022) Hemodynamic changes after left ventricular assist device implantation among heart failure patients with and without elevated pulmonary vascular resistance. Front Cardiovasc Med 9:875204. https:\/\/doi.org\/10.3389\/fcvm.2022.875204","journal-title":"Front Cardiovasc Med"},{"key":"428_CR19","doi-asserted-by":"publisher","first-page":"1023549","DOI":"10.3389\/fcvm.2022.1023549","volume":"9","author":"CA Bravo","year":"2022","unstructured":"Bravo CA, Navarro AG, Dhaliwal KK, Khorsandi M, Keenan JE, Mudigonda P, O\u2019Brien KD, Mahr C (2022) Right heart failure after left ventricular assist device: from mechanisms to treatments. Front Cardiovasc Med 9:1023549. https:\/\/doi.org\/10.3389\/fcvm.2022.1023549","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"428_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jjcc.2015.07.015","volume":"67","author":"T Ibe","year":"2016","unstructured":"Ibe T, Wada H, Sakakura K, Ikeda N, Yamada Y, Sugawara Y, Mitsuhashi T, Ako J, Fujita H, Momomura SI (2016) Pulmonary hypertension due to left heart disease: the prognostic implications of diastolic pulmonary vascular pressure gradient. J Cardiol 67(6):555\u2013559","journal-title":"J Cardiol"},{"issue":"1","key":"428_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","volume":"3","author":"E Tampakakis","year":"2015","unstructured":"Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ (2015) The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 3(1):9\u201316. https:\/\/doi.org\/10.1016\/j.jchf.2014.07.010","journal-title":"JACC Heart Fail"},{"issue":"16","key":"428_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012073","volume":"8","author":"H Alnsasra","year":"2019","unstructured":"Alnsasra H, Asleh R, Schettle SD, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Maltais S, Daly RC, Stulak JM, Rosenbaum AN, Behfar A, Kushwaha SS (2019) Diastolic pulmonary gradient as a predictor of right ventricular failure after left ventricular assist device implantation. J Am Heart Assoc 8(16):e012073. https:\/\/doi.org\/10.1161\/JAHA.119.012073","journal-title":"J Am Heart Assoc"},{"issue":"Suppl_2","key":"428_CR23","doi-asserted-by":"publisher","first-page":"A19236","DOI":"10.1161\/circ.130.suppl_2.19236","volume":"130","author":"T Thenappan","year":"2014","unstructured":"Thenappan T, Cogswell R, Kamdar F, Holley C, Harvey L, Colvin-Adams M, Eckman P, Adatya S, John R, Liao K, Pritzker MR (2014) Effect of continuous flow left ventricular assist device on diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in end stage heart failure patients with pulmonary hypertension. Circulation 130(Suppl_2):A19236","journal-title":"Circulation"},{"issue":"7","key":"428_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014801","volume":"9","author":"T Imamura","year":"2020","unstructured":"Imamura T, Narang N, Kim G, Raikhelkar J, Chung B, Nguyen A, Holzhauser L, Rodgers D, Kalantari S, Smith B, Ota T, Song T, Juricek C, Burkhoff D, Jeevanandam V, Sayer G, Uriel N (2020) Decoupling between diastolic pulmonary artery and pulmonary capillary wedge pressures is associated with right ventricular dysfunction and hemocompatibility-related adverse events in patients with left ventricular assist devices. J Am Heart Assoc 9(7):e014801. https:\/\/doi.org\/10.1161\/JAHA.119.014801","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"428_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008.Erratum.In:JHeartLungTransplant.2019;38(2):233","volume":"33","author":"RJ Tedford","year":"2014","unstructured":"Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS (2014) Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant 33(3):289\u2013297. https:\/\/doi.org\/10.1016\/j.healun.2013.11.008.Erratum.In:JHeartLungTransplant.2019;38(2):233","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"428_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ehf2.12284","volume":"5","author":"G Kumarasinghe","year":"2018","unstructured":"Kumarasinghe G, Jain P, Jabbour A, Lai J, Keogh AM, Kotlyar E, Jansz P, Macdonald PS, Hayward CS (2018) Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure. ESC Heart Fail 5(4):695\u2013702. https:\/\/doi.org\/10.1002\/ehf2.12284","journal-title":"ESC Heart Fail"},{"issue":"11","key":"428_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.healun.2010.06.002","volume":"29","author":"AC Alba","year":"2010","unstructured":"Alba AC, Rao V, Ross HJ, Jensen AS, Sander K, Gustafsson F, Delgado DH (2010) Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant 29(11):1253\u20131258. https:\/\/doi.org\/10.1016\/j.healun.2010.06.002","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"428_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","volume":"31","author":"D Zimpfer","year":"2007","unstructured":"Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, Zuckermann A, Wolner E, Wieselthaler G (2007) Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 31(4):698\u2013702. https:\/\/doi.org\/10.1016\/j.ejcts.2006.12.036","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"428_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.hlc.2018.04.299","volume":"28","author":"AM Selim","year":"2019","unstructured":"Selim AM, Wadhwani L, Burdorf A, Raichlin E, Lowes B, Zolty R (2019) Left Ventricular assist devices in pulmonary hypertension group 2 with significantly elevated pulmonary vascular resistance: a bridge to cure. Heart Lung Circ 28(6):946\u2013952. https:\/\/doi.org\/10.1016\/j.hlc.2018.04.299","journal-title":"Heart Lung Circ"},{"key":"428_CR30","doi-asserted-by":"publisher","unstructured":"Tsukashita M, Takayama H, Takeda K, Han J, Colombo PC, Yuzefpolskaya M, Topkara VK, Garan AR, Mancini DM, Kurlansky PA, Naka Y (2015) Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg 150(5):1352\u20131360, 1361.e1\u20132. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.07.012","DOI":"10.1016\/j.jtcvs.2015.07.012"},{"issue":"3","key":"428_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejcts.2010.05.031","volume":"39","author":"E Mikus","year":"2011","unstructured":"Mikus E, Stepanenko A, Krabatsch T, Dandel M, Lehmkuhl HB, Loforte A, Hetzer R, Potapov EV (2011) Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. Eur J Cardiothorac Surg 39(3):310\u2013316. https:\/\/doi.org\/10.1016\/j.ejcts.2010.05.031","journal-title":"Eur J Cardiothorac Surg"},{"key":"428_CR32","doi-asserted-by":"publisher","unstructured":"Uriel N, Imamura T, Sayer G, Agarwal R, Sims DB, Takayama H, John R, Pagani FD, Naka Y, Sundareswaran KS, Farrar DJ, Jorde UP, Heartmate II Clinical Investigators (2019) High transpulmonary artery gradient obtained at the time of left ventricular assist device implantation negatively affects survival after cardiac transplantation. J Card Fail 25(10):777\u2013784. https:\/\/doi.org\/10.1016\/j.cardfail.2019.03.010","DOI":"10.1016\/j.cardfail.2019.03.010"},{"issue":"1","key":"428_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jss.2004.05.013","volume":"123","author":"LO Thompson","year":"2005","unstructured":"Thompson LO, Skrabal CA, Loebe M, Lafuente JA, Roberts RR, Akgul A, Jones V, Bruckner BA, Thohan V, Noon GP, Youker KA (2005) Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 123(1):25\u201332. https:\/\/doi.org\/10.1016\/j.jss.2004.05.013","journal-title":"J Surg Res"},{"issue":"1","key":"428_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MAT.0000000000000614","volume":"64","author":"A Saidi","year":"2018","unstructured":"Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader F (2018) Favorable effects on pulmonary vascular hemodynamics with continuous-flow left ventricular assist devices are sustained 5 years after heart transplantation. ASAIO J 64(1):38\u201342. https:\/\/doi.org\/10.1097\/MAT.0000000000000614","journal-title":"ASAIO J"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00428-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:05:41Z","timestamp":1703081141000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00428-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00428-4","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of King Faisal Heart Center, was given a reference number (2181248) and waived from a specific consent as there is no personal identifiable data or photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}